Work

Duration of effectiveness of tuberculosis preventive treatment across various tuberculosis burden settings: a systematic review and individual-participant meta-analysis

Year: 2026
Type: review
Abstract: BACKGROUND: Millions of individuals at risk of tuberculosis are given tuberculosis preventive treatment (TPT) annually. However, questions remain regarding the duration of protection from TPT and potential variability across populations and settings with disparate tuberculosis risk. We aimed to assess the effect of TPT on time to tuberculosis among close contacts of individuals with tuberculosis and with evidence of Mycobacterium tuberculosis infection across high-burden, medium-burden, and low-burden settings. METHODS: In this systematic review and individual-participant meta-analysis, we searched MEDLINE, PubMed, Web of Science, BIOSIS, and Embase for cohort studies and randomised controlled trials published between Jan 1, 1998, and Aug 28, 2023. Studies were eligible if they included individuals (of any age) with household or close exposure to a person with microbiologically or clinically diagnosed tuberculosis (contacts); had at least 6 months of contact follow-up from baseline; and reported start and end of follow-up dates or days of follow-up. We pooled individual-participant data from included cohorts, including contact and index patient characteristics and setting. Analyses were restricted to participants who tested positive for M tuberculosis infection at baseline and stratified by background tuberculosis burden (low burden was defined as a country-level annual incidence of <20 per 100 000 population, medium as 20-100 per 100 000 population, and high as >100 per 100 000 population). The primary outcome was incident tuberculosis, which was defined as tuberculosis diagnosed more than 90 days after baseline. We calculated incidence rates by TPT status, generated Nelson-Aalen cumulative hazard plots, and estimated adjusted hazard ratios (HRs) using mixed-effects Cox models with a time interaction. This study is registered with PROSPERO, CRD42018087022. FINDINGS: Of 466 523 participants from 47 studies, we included 84 128 individuals from 44 cohort studies across 24 countries. TPT was highly protective within the first year but declined over the course of follow-up in all settings, with greater effects observed in low-burden and medium-burden settings. At 1 year, the adjusted HR was 0·57 (95% CI 0·31-1·07) in high-burden settings, 0·14 (0·09-0·21) in medium-burden settings, and 0·21 (0·17-0·26) in low-burden settings. The protective effect persisted up to the end of follow-up in medium-burden settings (adjusted HR at 8 years 0·15 [95% CI 0·07-0·33]) and up to 13 years in low-burden settings (0·65 [0·43-1·00]). In medium-burden and low-burden settings, participants who completed TPT initially had lower risk of tuberculosis than those who did not complete TPT (adjusted HR at 1 year 0·59 [95% CI 0·36-0·95]); within 2 years, these groups were not statistically different (adjusted HR at 2 years 0·72 [0·41-1·26]) and both showed strong protection for at least 8 years. INTERPRETATION: Among close contacts with evidence of M tuberculosis infection, we found that the initial protection from TPT eroded relatively quickly in high-burden settings, but was sustained long-term in medium-burden and low-burden settings. In medium-burden and low-burden settings, completing TPT provided greater initial protection, but TPT non-completers had similar long-term tuberculosis risk. FUNDING: None.
Institutions: Boston University, Boston Medical Center, University College London, Ministry of Health, Johns Hopkins University, Instituto Gonçalo Moniz, Fundação Oswaldo Cruz, Pontificia Universidad Católica de Chile, Agencia Nacional de Investigación y Desarrollo, Harvard University, Universidad de Antioquia, Karolinska University Hospital, Universidad de Buenos Aires, Inserm, Université de Montpellier, Institut de Recherche pour le Développement, Recherches Translationnelles sur le VIH et les Maladies Infectieuses, University of California, Los Angeles, Instituto Oswaldo Cruz, Georgia State University, National Center for Tuberculosis and Lung Disease, National Taiwan University, National Taiwan University Hospital, Taiwan Centers for Disease Control, Universiti Brunei Darussalam, Jiangsu Provincial Center for Disease Control and Prevention, Liverpool Hospital, UNSW Sydney, Université Paris Cité, Hôpital Robert-Debré, Royal Children's Hospital, The University of Melbourne, Murdoch Children's Research Institute, Helmholtz Centre for Infection Research, Hessisches Landesamt für Gesundheit und Pflege, Stellenbosch University, University of Otago, Epicentre, University of California, Irvine, B. J. Medical College & Sassoon Hospital, Geisinger Medical Center, Geisinger Health System, Universidade Federal do Rio de Janeiro, Wan Fang Hospital, Taipei Medical University, Fu Jen Catholic University, University of Alberta, University of Glasgow, Baylor College of Medicine, Texas Children's Hospital, Universidad Pontificia Bolivariana, University of the Witwatersrand, Perinatal HIV Research Unit, Aligarh Muslim University, Brigham and Women's Hospital, Region Stockholm, Centre Hospitalier de Valence, Shanghai Medical College of Fudan University, Fudan University, GGD Amsterdam, Imperial College London, McGill University, Jamia Hamdard, Datta Meghe Institute of Higher Education and Research, University of Georgia, Era's Lucknow Medical College and Hospital, University Hospitals of Cleveland, Mulago Hospital, University Hospitals Cleveland Medical Center, Case Western Reserve University, Makerere University, Universitas Gadjah Mada, Rumah Sakit Umum Pusat Dr. Sardjito, New York City Department of Health and Mental Hygiene, Government of New York City, Radboud University Medical Center, Amalia Kinderziekenhuis, Emory University, University of California, Berkeley
Language: English
Field: Medicine
Open Access status: hybrid
Estimated APC paid: $7,280
OpenAlex ID: W7213607429
FWCI: 1.921
Cites: 26
Cited by: 2
Related to: 8